[1] HE L Y, YANG F Q, TANG P, et al.Regulation of the intestinal flora:a potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus[J].Biomedicine & Pharmacotherapy, 2022, 151:113091.
[2] 赵群, 王文绢.2型糖尿病血管并发症危险因素控制研究进展[J].中国慢性病预防与控制, 2022, 30(4):302-306.
ZHAO Q, WANG W J.Progress in control of risk factors for vascular complications in type 2 diabetes mellitus[J].Chinese Journal of Prevention and Control of Chronic Diseases, 2022, 30(4):302-306.
[3] ZAMORA-ROS R, FOROUHI N G, SHARP S J, et al.The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations:The EPIC-InterAct study[J].Diabetes Care, 2013, 36(12):3961-3970.
[4] JU M Z, LIU Y Q, LI M Y, et al.Baicalin improves intestinal microecology and abnormal metabolism induced by high-fat diet[J].European Journal of Pharmacology, 2019, 857:172457.
[5] QIN J J, LI Y R, CAI Z M, et al.A metagenome-wide association study of gut microbiota in type 2 diabetes[J].Nature, 2012, 490(7418):55-60.
[6] REN X X, SUN Y, GUO Q F, et al.Ameliorating effect of the total flavonoids of Morus nigra L.on prediabetic mice based on regulation of inflammation and insulin sensitization[J].Journal of Agricultural and Food Chemistry, 2022, 70(39):12484-12501.
[7] XU H, LUO J, HUANG J, et al.Flavonoids intake and risk of type 2 diabetes mellitus:A meta-analysis of prospective cohort studies[J].Medicine, 2018, 97(19):e0686.
[8] LIN X C, ZHANG I, LI A, et al.Cocoa flavanol intake and biomarkers for cardiometabolic health:A systematic review and meta-analysis of randomized controlled trials[J].The Journal of Nutrition, 2016, 146(11):2325-2333.
[9] CURTIS P J, SAMPSON M, POTTER J, et al.Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes:A 1-year, double-blind, randomized, controlled trial[J].Diabetes Care, 2012, 35(2):226-232.
[10] ASADI A, SHIDFAR F, SAFARI M, et al.Efficacy of Melissa officinalis L.(lemon balm) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes:A randomized, double-blind, clinical trial[J].Phytotherapy Research, 2019, 33(3):651-659.
[11] SHABBIR U, RUBAB M, DALIRI E B M, et al.Curcumin, quercetin, catechins and metabolic diseases:The role of gut microbiota[J].Nutrients, 2021, 13(1):206.
[12] 陈斌, 刘洁, 詹敏敏, 等.黄酮类化合物与肠道菌群互作研究进展[J].中国食品学报, 2022, 22(6):369-381.
CHEN B, LIU J, ZHAN M M, et al.Research progress in the interaction between flavonoids and gut microbiota[J].Journal of Chinese Institute of Food Science and Technology, 2022, 22(6):369-381.
[13] MUROTA K, NAKAMURA Y, UEHARA M.Flavonoid metabolism:The interaction of metabolites and gut microbiota[J].Bioscience, Biotechnology, and Biochemistry, 2018, 82(4):600-610.
[14] STRAT K M, ROWLEY T J, SMITHSON A T, et al.Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders[J].The Journal of Nutritional Biochemistry, 2016, 35:1-21.
[15] KRAVCHENKO L V, AVREN′EVA L I, GUSEVA G V, et al.Effects of polyphenols on activity of glycosyl hydrolases in the cecum of rats fed obesity inducing diets[J].Voprosy Pitaniia, 2019, 88(3):63-68.
[16] FENG X, LI Y, BROBBEY OPPONG M, et al.Insights into the intestinal bacterial metabolism of flavonoids and the bioactivities of their microbe-derived ring cleavage metabolites[J].Drug Metabolism Reviews, 2018, 50(3):343-356.
[17] WINTER J, POPOFF M R, GRIMONT P, et al.Clostridium Orbiscindens sp.nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring[J].International Journal of Systematic Bacteriology, 1991, 41(3):355-357.
[18] SANTANGELO R, SILVESTRINI A, MANCUSO C.Ginsenosides, catechins, quercetin and gut microbiota:Current evidence of challenging interactions[J].Food and Chemical Toxicology, 2019, 123:42-49.
[19] PEREIRA-CARO G, FERNÁNDEZ-QUIRÓ S B, LUDWIG I A, et al.Catabolism of citrus flavanones by the probiotics Bifidobacterium longum and Lactobacillus rhamnosus[J].European Journal of Nutrition, 2018, 57(1):231-242.
[20] PEREIRA-CARO G, BORGES G, KY I, et al.In vitro colonic catabolism of orange juice (poly)phenols[J].Molecular Nutrition & Food Research, 2015, 59(3):465-475.
[21] GAYA P, MEDINA M, SÁNCHEZ-JIMÉNEZ A, et al.Phytoestrogen metabolism by adult human gut microbiota[J].Molecules, 2016, 21(8):1034.
[22] 李硕, 倪向敏, 徐喆, 等.雌马酚对2型糖尿病大鼠的肾脏保护作用[J].陆军军医大学学报, 2022, 44(10):1009-1017.
LI S, NI X M, XU J Z, et al.Renal protective effect of equol on type 2 diabetic rats[J].Journal of Army Medical University, 2022, 44(10):1009-1017.
[23] JIANG H, YAMASHITA Y, NAKAMURA A, et al.Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes[J].Scientific Reports, 2019, 9(1):2690.
[24] TAKAGAKI A, YOSHIOKA Y, YAMASHITA Y, et al.Effects of microbial metabolites of (-)-Epigallocatechin Gallate on glucose uptake in L6 skeletal muscle cell and glucose tolerance in ICR Mice[J].Biological and Pharmaceutical Bulletin, 2019, 42(2):212-221.
[25] ORMAZABAL P, SCAZZOCCHIO B, VARÌ R, et al.Effect of protocatechuic acid on insulin responsiveness and inflammation in visceral adipose tissue from obese individuals:Possible role for PTP1B[J].International Journal of Obesity, 2018, 42(12):2012-2021.
[26] CARRASCO-POZO C, GOTTELAND M, CASTILLO R L, et al.3,4-dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, protects against pancreatic β-cells dysfunction induced by high cholesterol[J].Experimental Cell Research, 2015, 334(2):270-282.
[27] FERNÁNDEZ-MILLÁN E, RAMOS S, ALVAREZ C, et al.Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways[J].Food and Chemical Toxicology, 2014, 66:245-253.
[28] 刘凯. S型雌马酚调控Txnip表达对HepG2细胞胰岛素敏感性的影响及机制研究[D].重庆:第三军医大学, 2013.
LIU K.Effect of S-equol on insulin sensitivity in HepG2 and regulatory mechanisms involved[D].Chongqing:The Third Military Medical University, 2013.
[29] 何雅静, 张群琳, 谷利伟, 等.柑橘中酚酸类化合物及其生物活性与机理的研究进展[J].食品与发酵工业, 2020, 46(15):301-306.
HE Y J, ZHANG Q L, GU L W, et al.Research progress on phenolic acids in citrus and their biological activities and mechanisms[J].Food and Fermentation Industries, 2020, 46(15):301-306.
[30] 梅桂雪, 孙捷, 殷姝君, 等.黄酮类化合物防治糖尿病及其并发症的研究进展[J].食品与药品, 2018, 20(4):307-312.
MEI G X, SUN J, YIN S J, et al.Research progress on flavonoids for prevention and treatment of diabetes mellitus and its complications[J].Food and Drug, 2018, 20(4):307-312.
[31] QIAO Y, ZHANG Z C, ZHAI Y Y, et al.Apigenin alleviates obesity-associated metabolic syndrome by regulating the composition of the gut microbiome[J].Frontiers in Microbiology, 2022, 12:805827.
[32] ZHANG Y L, XU Y N, ZHANG L, et al.Licorice extract ameliorates hyperglycemia through reshaping gut microbiota structure and inhibiting TLR4/NF-κB signaling pathway in type 2 diabetic mice[J].Food Research International, 2022, 153:110945.
[33] CAESAR R.Pharmacologic and nonpharmacologic therapies for the gut microbiota in type 2 diabetes[J].Canadian Journal of Diabetes, 2019, 43(3):224-231.
[34] LIU L L, ZHANG J H, CHENG Y, et al.Gut microbiota:A new target for T2DM prevention and treatment[J].Frontiers in Endocrinology, 2022, 13:958218.
[35] YOSHIDA H, ISHII M, AKAGAWA M.Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway[J].Archives of Biochemistry and Biophysics, 2019, 672:108057.
[36] MA Q T, LI Y Q, LI P F, et al.Research progress in the relationship between type 2 diabetes mellitus and intestinal flora[J].Biomedicine & Pharmacotherapy, 2019, 117:109138.
[37] LIMA A C D, CECATTI C, FIDÉLIX M P, et al.Effect of daily consumption of orange juice on the levels of blood glucose, lipids, and gut microbiota metabolites:Controlled clinical trials[J].Journal of Medicinal Food, 2019, 22(2):202-210.
[38] ZHANG Y, BOBE G, REVEL J S, et al.Improvements in metabolic syndrome by xanthohumol derivatives are linked to altered gut microbiota and bile acid metabolism[J].Molecular Nutrition & Food Research, 2020, 64(1):e1900789.
[39] GUPTA S, MARATHA A, SIEDNIENKO J, et al.Analysis of inflammatory cytokine and TLR expression levels in type 2 diabetes with complications[J].Scientific Reports, 2017, 7(1):7633.
[40] ZHANG B W, SUN W L, YU N, et al.Anti-diabetic effect of baicalein is associated with the modulation of gut microbiota in streptozotocin and high-fat-diet induced diabetic rats[J].Journal of Functional Foods, 2018, 46:256-267.
[41] DE MELLO V D, PAANANEN J, LINDSTRÖ M J, et al.Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the finnish diabetes prevention study[J].Scientific Reports, 2017, 7(1):46337.
[42] TUOMAINEN M, LINDSTR M J, LEHTONEN M, et al.Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals[J].Nutrition & Diabetes, 2018, 8(1):35.
[43] WU F, LEI H H, CHEN G, et al.In vitro and in vivo studies reveal that hesperetin-7-O-glucoside, a naturally occurring monoglucoside, exhibits strong anti-inflammatory capacity[J].Journal of Agricultural and Food Chemistry, 2021, 69(43):12753-12762.
[44] YU L L, SONG P K, ZHU Q R, et al.The dietary branched-chain amino acids transition and risk of type 2 diabetes among chinese adults from 1997 to 2015:Based on seven cross-sectional studies and a prospective cohort study[J].Frontiers in Nutrition, 2022, 9:881847.
[45] NAWAZ S S, SIDDIQUI K.The emerging role of branch chain amino acids in the prediction of diabetes:A brief review[J].Current Diabetes Reviews, 2020, 16(6):532-537.
[46] FERNÁNDEZ-MILLÁN E, RAMOS S, ÁLVAREZ-CILLEROS D, et al.Urinary metabolomics study on the protective role of cocoa in zucker diabetic rats via 1H-NMR-based approach[J].Nutrients, 2022, 14(19):4127.
